CN1188758A - 芳氨基亚甲基樟脑衍生物 - Google Patents
芳氨基亚甲基樟脑衍生物 Download PDFInfo
- Publication number
- CN1188758A CN1188758A CN98103790A CN98103790A CN1188758A CN 1188758 A CN1188758 A CN 1188758A CN 98103790 A CN98103790 A CN 98103790A CN 98103790 A CN98103790 A CN 98103790A CN 1188758 A CN1188758 A CN 1188758A
- Authority
- CN
- China
- Prior art keywords
- aryl
- acid
- compound
- derivatives
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 R3 H Chemical group 0.000 claims abstract description 23
- 125000003118 aryl group Chemical group 0.000 claims abstract description 21
- 239000000516 sunscreening agent Substances 0.000 claims abstract description 10
- 125000001072 heteroaryl group Chemical group 0.000 claims abstract description 9
- 150000001875 compounds Chemical class 0.000 claims description 16
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 3
- 239000002537 cosmetic Substances 0.000 abstract description 5
- 125000003107 substituted aryl group Chemical group 0.000 abstract 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 16
- 239000003921 oil Substances 0.000 description 13
- 235000019198 oils Nutrition 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical class C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 239000004166 Lanolin Chemical class 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical class CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 125000002541 furyl group Chemical group 0.000 description 3
- 239000002480 mineral oil Substances 0.000 description 3
- 235000010446 mineral oil Nutrition 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 125000004076 pyridyl group Chemical group 0.000 description 3
- 125000001544 thienyl group Chemical group 0.000 description 3
- DSSYKIVIOFKYAU-OIBJUYFYSA-N (S)-camphor Chemical compound C1C[C@]2(C)C(=O)C[C@H]1C2(C)C DSSYKIVIOFKYAU-OIBJUYFYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- SIQJPQQLXKTTEE-UHFFFAOYSA-N 2-cinnamylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical class CC1(C)C2CCC1(C)C(=O)C2=CC=CC1=CC=CC=C1 SIQJPQQLXKTTEE-UHFFFAOYSA-N 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- 206010048768 Dermatosis Diseases 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical class CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 239000000305 astragalus gummifer gum Substances 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- LPIQUOYDBNQMRZ-UHFFFAOYSA-N cyclopentene Chemical compound C1CC=CC1 LPIQUOYDBNQMRZ-UHFFFAOYSA-N 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N naphthalene-acid Natural products C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- OIQXFRANQVWXJF-QBFSEMIESA-N (2z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical class CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1 OIQXFRANQVWXJF-QBFSEMIESA-N 0.000 description 1
- KUWCMTFKTVOJID-UHFFFAOYSA-N 1,2-icosanediol Chemical group CCCCCCCCCCCCCCCCCCC(O)CO KUWCMTFKTVOJID-UHFFFAOYSA-N 0.000 description 1
- ZEMPKEQAKRGZGQ-AAKVHIHISA-N 2,3-bis[[(z)-12-hydroxyoctadec-9-enoyl]oxy]propyl (z)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCC(O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(O)CCCCCC)COC(=O)CCCCCCC\C=C/CC(O)CCCCCC ZEMPKEQAKRGZGQ-AAKVHIHISA-N 0.000 description 1
- QMIBDVOQOZDSEN-UHFFFAOYSA-N 2-phenylbenzimidazole-2-sulfonic acid Chemical compound N1=C2C=CC=CC2=NC1(S(=O)(=O)O)C1=CC=CC=C1 QMIBDVOQOZDSEN-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- XDERNIJRJWFQTH-UHFFFAOYSA-N CCC1=CC=C(N(C(=O)OCCCCCC)C2=NC=NC=N2)C=C1 Chemical class CCC1=CC=C(N(C(=O)OCCCCCC)C2=NC=NC=N2)C=C1 XDERNIJRJWFQTH-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 240000006474 Theobroma bicolor Species 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- SZPWXAOBLNYOHY-UHFFFAOYSA-N [C]1=CC=NC2=CC=CC=C12 Chemical group [C]1=CC=NC2=CC=CC=C12 SZPWXAOBLNYOHY-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 1
- 239000003849 aromatic solvent Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000008407 cosmetic solvent Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000005908 glyceryl ester group Chemical group 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052806 inorganic carbonate Inorganic materials 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- YLGXILFCIXHCMC-JHGZEJCSSA-N methyl cellulose Chemical compound COC1C(OC)C(OC)C(COC)O[C@H]1O[C@H]1C(OC)C(OC)C(OC)OC1COC YLGXILFCIXHCMC-JHGZEJCSSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000012184 mineral wax Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- KPMKEVXVVHNIEY-RITPCOANSA-N norcamphor Chemical group C1C[C@@H]2C(=O)C[C@H]1C2 KPMKEVXVVHNIEY-RITPCOANSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000003883 ointment base Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- CFHIDWOYWUOIHU-UHFFFAOYSA-N oxomethyl Chemical compound O=[CH] CFHIDWOYWUOIHU-UHFFFAOYSA-N 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- RGSFGYAAUTVSQA-UHFFFAOYSA-N pentamethylene Natural products C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003586 protic polar solvent Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000004857 zone melting Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
- C07C225/14—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
式(1)的芳氨基亚甲基樟脑衍生物,式中C=C双键是Z或E构型,而其中各变量具有以下的意义:R1为H、CH3,R2为H、C1~C6-烷基、C3~C8-环烷基、C2~C6-链烯基、C3~C8-环烯基、芳基或取代的芳基,R3为H、C1~C6-烷基、C3~C8-环烷基、芳基、取代的芳基、C1~C6-烷氧基、C1~C8-酰基,Ar为芳基、取代的芳基、杂芳基或取代的杂芳基,作为防晒剂的应用,特别是在化妆品和药物配方里的应用。
Description
以樟脑衍生物为主要成分的防晒剂是已知的。DE 23 36 219描述了在苯环的4位未取代的或由甲基、甲氧基或氯取代的磺化的亚苄基-和亚肉桂基樟脑衍生物。
DE 34 45 712描述了一些适于作为用于治疗皮肤病药物的未取代的樟脑衍生物,优选的是亚苄基樟脑衍生物。
DE 44 26 216描述了能够作为防晒剂和用于防止炎症和皮肤疾病的亚苄基降樟脑衍生物。
DE 44 24 489描述了用于制备取代的4-亚甲基肉桂酸衍生物的方法。
以插烯的酰胺类为主要成分的防晒剂同样是已知的。DE 33 16 287描述了一些有开链结构的并且适于在防晒剂组合物中作为滤光剂的插烯的酰胺。
要满足打算用来作为紫外线-A滤光剂的防晒剂的要求有很多(Sunscreens,ed.N.J.Lowe,N.A.Shaath,Marcel Dekker Inc.,NewYork 1990,230-231)。最主要的是:
1) 在从320-360nm紫外线A区段有吸收最大值;
2) 在该区段有高的吸收率;
3) 无色,即大于400nm的吸收应该趋于0地小以便防止给皮肤保护制品着色或在使用后给衣物着色;
4) 是光-和热稳定的;
5) 与皮肤相容并且对皮肤不引起刺激或毒性作用;
6) 很好地黏附到皮肤上;
7) 与化妆物质相容并且易溶于化妆溶剂和组合物里;
8) 是异构体纯的。
已知的亚肉桂基樟脑衍生物是广谱紫外线过滤吸收剂,在紫外线-A区段的保护作用不充分。此外,它们的溶解性,尤其是在油相里的溶解性对于某些应用是不令人满意的。
本发明的目的是提供一种适于作为紫外线-A滤光剂并且具有特别良好的光稳定性、在油相里溶解性良好的和在紫外线-A区段有令人满意的吸收极大值的化合物。
式中C=C双键是Z或E构型,而
R1=H、CH3,
R2=H、C1~C6-烷基、C3~C8-环烷基、C2~C6-链烯基、C3~C8-环烯基、芳基或取代的芳基,
R3=H、C1~C6-烷基、C3~C8-环烷基、芳基、取代的芳基、C1~C6-烷氧基、C1~C8-酰基,
Ar=芳基、取代的芳基、杂芳基、取代的杂芳基。
(1)是通过将式(2)的羟基亚甲基樟脑化合物(按照由L.Claisen,Ann.281,1894,306的描述制备)在一种碱或酸的存在下,在加入或不加入一种或几种溶剂及在0~200℃下与式(3)的胺类反应制备的。
(2)和(3)以等摩尔量反应制备根据本发明的化合物。
这个反应通常在例如甲醇或乙醇之类的质子溶剂(protic solvents)里进行的。不过,这个反也可以在醚中进行,例如二乙醚或四氢呋喃,在C1~C20石蜡混合物中或诸如己烷、甲苯或二甲苯的脂族或芳族溶剂里进行。
但这个反应也能够在没有溶剂的情况下进行。优选在低级醇里进行这个反应,以获得好的时空产率,只使用足量的溶剂用以产生在反应温度下可以搅拌的混合物。
(2)和(3)能够以任意的顺序进行反应。催化剂可以在最初就存在或者加入进去。这个反应也能够以一釜反应的形式进行。还可以将(2)首先与催化剂一起加入,再将(3)加入进去,或者相反。也可以将催化剂先与(3)一起加入而将(2)再加入进去。
反应能在0℃~+200℃下进行。优选的温度范围为20℃~100℃,最优选为60℃~90℃。
反应时间直接取决于温度。通常这个反应在特别优选的温度范围内在1~5小时之后完成。在更低的温度或更低的稳定状态浓度下,反应时间可能显著地增加而可能达到48小时。
能够使用的催化剂是任意的有机或无机碱或它们的混合物。典型的碱催化剂的例子是吡啶、三甲胺或无机碳酸盐。这些碱在混合物中可以呈均相或呈多相。
这个反应优选使用的催化剂是有机或无机酸或它们的混合物。可供使用的无机酸尤其可以是盐酸、硫酸、硝酸和/或磷酸。
可供使用的有机酸尤其可以是甲酸、乙酸、草酸、琥珀酸、抗坏血酸和/或诸如甲磺酸或甲苯磺酸之类的磺酸。
此外,酸离子交换剂同样也适于作为(2)与(3)反应的催化剂。
所要求的产品(1)采用常规的技术分离,例如沉积、过滤、离心法、相分离和溶剂萃取。
所要求的产品(1)可通过从有机溶剂和它们的混合物和/或水中再结晶来纯化。混合物优选含醇的。
纯化也可以通过区域熔融和色谱法以及蒸馏法进行。
本发明的化合物(1)可以含有樟脑部分(R1=CH3)或降樟脑部分(R1=H)。
R2有以下的意义:H; C1~C6-烷基,优选C3-和C4-烷基,例如n-丙基、异丙基、n-丁基、异丁基、叔丁基;C3~C8-环烷基,优选环丙基、环丁基、环戊基、环己基;C2~C6-链烯基,优选乙烯基、丙烯基;C3~C8-环烯基,优选环戊烯基和环己烯基;芳基或取代的芳基,优选苯基、单或二取代的苯基、萘基或杂芳基,例如呋喃基、噻吩基或吡啶基。R3有以下的意义:H;C1~C6-烷基,优选C1~C4烷基,例如甲基、乙基、n-丙基、异丙基、n-丁基、异丁基、叔丁基;C3~C8-环烷基,优选环丙基、环丁基、环戊基、环己基;芳基或取代的芳基;优选苯基、单或二取代的苯基;C1~C6-烷氧基,优选甲氧基、乙氧基、n-丙氧基或异丙氧基;C1~C8-酰基,优选甲酰基、乙酰基、丙酰基、新戊酰基、n-丁酰基、异丁酰基、苯甲酰基。Ar有以下的意义:芳基,优选苯基、萘基;杂芳基,优选呋喃基、噻吩基、吡咯基或吡啶基;取代的芳基,优选单或二取代的苯基,取代的杂芳基,优选单或二取代的呋喃基、噻吩基、吡咯基或吡啶基,这里取代基可以是相同的或不同的,并且具有以下的意义:烷基、环烷基、烷氧基、氨基、烷氨基、羟基、卤素、酰基,特别优选酰氧基或酰氨基,和烷氧基羰基或氨基羰基、羧基、磺基或氨基磺酰基。
在本发明的式(1)的芳氨基亚甲基樟脑衍生物里的C=C双键在合成之后既呈Z构型也呈E构型。结晶优先生成其中在C=C双键上的取代基是在反位的式(1)的化合物。
本发明的化合物(1)以其高的光稳定性而著称并且特别适用于作为防晒剂,尤其是作为紫外线-A过滤吸收剂,特别是用于化妆品和药物应用。不过这种紫外线吸收作用也能够用于稳定塑料、染料配方或表面涂料。
化妆品或化妆组合物中化合物(1)的含量,除了在化妆品里常规的赋形剂和稀释剂之外,通常为配方(包含或不包含常规的化妆辅助剂)重量的0.1~15%,优选5~10%。
载体、辅助剂或稀释剂的性质决定了防晒剂最终制品是否为一种溶液、油、膏剂、软膏、洗剂、凝胶或粉剂。这一类型的组合物在例如Seifen,Oele,Fette,Wachse(1955),147的杂志里有论述。
通常使用的和适于作为化妆辅助剂是,例如,诸如脂肪醇乙氧基化物、脱水山梨醇脂肪酸酯或羊毛脂衍生物之类的乳化剂,诸如羰基甲基纤维素或交联的聚丙烯酸之类的增稠剂,防腐剂和香味剂。
例如,防晒油以植物油为基,例如花生油、橄榄油、芝麻油、棉子油、椰子油、葡萄子油、蓖麻油,或以矿物油为基,例如液体矿脂或,尤其是液态石蜡、合成脂肪酸酯和甘油酯。软膏基质的例子为矿酯、羊毛脂、优赛林(eucerin)或聚乙二醇。
膏剂基质的例子为高脂肪乳油、甘油、聚糖和Tylose乳油,和以脂肪与鲸蜡醇蜡为基的乳油、羊毛脂乳油、可可油、蜂蜡、硬脂酸、十八烷醇、一硬脂酸甘油酯、天然或矿物油和脂。
乳液基质的例子为硬脂酰乙二醇,诸如杏仁油、液体石蜡和矿酯之类的植物油和/或矿物油和水的混合物,或乙醇、水、羊毛脂和黄蓍胶的混合物,或乙醇、硬脂精、水、黄蓍胶和甘油的混合物,或硬脂酸、液体石蜡、丙醇或异丙醇以及水的混合物。
本发明的化合物能够在适合的组合物里作为唯一的紫外线吸收剂使用;不过它们也可以与其它紫外线吸收剂特别是与紫外线-B吸收剂结合使用。
这类化合物的例子是p-氨基苯甲酸乙酯,p-甲氧基肉桂酸-2-乙基己基酯,2-氰基-3,3-二苯基丙烯酸-2-乙基己酯,2-苯基苯并咪唑磺酸和盐,2-羟基-4-甲氧基二苯酮,2-羟基-4-甲氧基二苯酮-5-磺酸,3-(4-甲基亚苄基)-d,l-樟脑,2,4,6-三(p-2-乙基己氧基羰基苯胺基)-1,3,5-三嗪。
以下通用的方法特别优选用于制备本发明的化合物(1):
将等摩尔量(22mmol)的羟基亚甲基樟脑化合物(2)和胺(3)溶于20ml甲醇里,并且在加入0.1ml浓盐酸之后在65℃加热2小时。在反应混合物已经冷却至10℃之后,所要求的产品(1)结晶出来并且能够通过过滤、洗涤和随后的干燥分离出分析纯的所要求的产品(1)。
实施例1
采用通用的方法将4g(22mmol)羟基亚甲基樟脑与5.45g(22mmol)p-氨基苯甲酸乙基己酯反应以生成9g下式的化合物:UV(CH3OH):λmax=358nm,E1 1=1044IR:υ=3220,2959,1711,1692,1636,1602(s),1587,1263(s),1176,1105,1072cm-1。1H-NMR(CDCl3): δ=9.87(d,1H,J=11.2Hz),
7.95(d,2H,J=7.6Hz),
6.91(m,3H),
4.16(d,2H,J=8.2Hz),
2.40(m,1H),
2.01(m,1H),
1.68(m,2H),
1.32(m,10H),
0.96(m,15H)。
实施例2
采用通用的方法将4g(22mmol)羟基亚甲基樟脑与4.29g(22mmol)O-氨基苯甲酸丁基酯反应以生成4.9g下式的化合物:UV(CH3OH):λmax=358nm,E1 1=802IR:υ=3274,2943,1687,1622(s),1602,1592,1272,1246,1156cm-1。1H-NMR(CDCl3): δ=10.13(d,1H,J=16.2Hz),
7.98(d,1H,J=6.9Hz),
7.68(d,1H,J=16.2Hz),
7.49(t,1H,J=7.2Hz),
7.21(d,1H,J=6.9Hz),
6.87(d,1H,J=7.2Hz),
4.37(t,2H,J=8.1Hz),
2.81(m,1H),
2.11(m,1H),
1.4-1.6(m,9H),
0.99(m,10H)。
实施例3
在表1里的化合物3.1~3.15按照实施例1和2制备表1
化合物 | R1 | R2 | R3 | Ar |
3.1 | CH3 | H | H | 4-CH3O-Ph |
3.2 | CH3 | H | H | 2,4-Di-CH3O-Ph |
3.3 | CH3 | CH3 | H | 4-CH3O-Ph |
3.4 | CH3 | CH3 | CH3 | 4-CH3O-Ph |
3.5 | H | H | H | 4-CH3O-Ph |
3.6 | CH3 | H | H | 2-(H2N-CO)-Ph |
3.7 | CH3 | H | H | 4-(H2N-CO)-Ph |
3.8 | H | H | H | 2-(CH3O-CO)-Ph |
3.9 | H | H | H | 4-(C8H17O-CO)-Ph |
3.10 | CH3 | H | H | 4-quinolinyl |
3.11 | CH3 | H | H | 2-CO2H-Ph |
3.12 | CH3 | H | H | 4-SO3H-Ph |
3.13 | CH3 | H | H | 4-SO2NH2-Ph |
3.14 | CH3 | CH3 | H | 2-CO2H-Ph |
3.15 | CH3 | CH3 | H | 2-(nC4H9O-CO)-Ph |
Claims (5)
2、如权利要求1所述的化合物,其中C=C双键是E构型。
3、如权利要求1所述的化合物,其中R1是CH3,R2=R3=H和Ar是2-(烷氧基羰基)苯基。
4、如权利要求1~3所述的化合物作为防晒剂的应用。
5、如权利要求4所述的在化妆品或药物配方里的应用。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19701448.8 | 1997-01-17 | ||
DE19701448A DE19701448A1 (de) | 1997-01-17 | 1997-01-17 | Arylaminomethylencampherderivate |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1188758A true CN1188758A (zh) | 1998-07-29 |
CN1149188C CN1149188C (zh) | 2004-05-12 |
Family
ID=7817607
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB981037909A Expired - Fee Related CN1149188C (zh) | 1997-01-17 | 1998-01-13 | 芳氨基亚甲基樟脑衍生物 |
Country Status (7)
Country | Link |
---|---|
US (1) | US5932195A (zh) |
EP (1) | EP0854133B1 (zh) |
JP (1) | JP4154018B2 (zh) |
CN (1) | CN1149188C (zh) |
AU (1) | AU748609B2 (zh) |
DE (2) | DE19701448A1 (zh) |
ES (1) | ES2179389T3 (zh) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2336219A1 (de) * | 1973-07-17 | 1975-02-20 | Merck Patent Gmbh | Campherderivate |
US4663155A (en) * | 1982-05-05 | 1987-05-05 | Johnson & Johnson Baby Products Company | Sunscreen compositions |
LU85144A1 (fr) * | 1983-12-16 | 1985-09-12 | Oreal | Derives insatures du camphre,leurs procedes de preparation et leur application dans le domaine therapeutique et cosmetique |
DE4424489A1 (de) * | 1994-07-12 | 1996-01-18 | Merck Patent Gmbh | Verfahren zur Herstellung von substituierten 4-Methyliden-Zimtsäure-Derivaten |
DE4426216A1 (de) * | 1994-07-23 | 1996-01-25 | Merck Patent Gmbh | Benzyliden-Norcampher-Derivate |
-
1997
- 1997-01-17 DE DE19701448A patent/DE19701448A1/de not_active Withdrawn
-
1998
- 1998-01-13 EP EP98100435A patent/EP0854133B1/de not_active Expired - Lifetime
- 1998-01-13 DE DE59804542T patent/DE59804542D1/de not_active Expired - Lifetime
- 1998-01-13 US US09/006,175 patent/US5932195A/en not_active Expired - Fee Related
- 1998-01-13 CN CNB981037909A patent/CN1149188C/zh not_active Expired - Fee Related
- 1998-01-13 ES ES98100435T patent/ES2179389T3/es not_active Expired - Lifetime
- 1998-01-14 JP JP00591898A patent/JP4154018B2/ja not_active Expired - Fee Related
- 1998-01-16 AU AU52109/98A patent/AU748609B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
DE59804542D1 (de) | 2002-08-01 |
JPH10226671A (ja) | 1998-08-25 |
MX9800488A (es) | 1998-10-31 |
EP0854133A1 (de) | 1998-07-22 |
EP0854133B1 (de) | 2002-06-26 |
US5932195A (en) | 1999-08-03 |
CN1149188C (zh) | 2004-05-12 |
AU5210998A (en) | 1998-07-23 |
ES2179389T3 (es) | 2003-01-16 |
JP4154018B2 (ja) | 2008-09-24 |
DE19701448A1 (de) | 1998-07-23 |
AU748609B2 (en) | 2002-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2103297B1 (de) | Polymerisierbare Zusammensetzung mit mehrere Germanium-Atome enthaltenden Initiatoren | |
DE10014669C1 (de) | Verfahren zur Herstellung von Arteethern aus Dihydroartemisinin | |
CN105461624A (zh) | 一种磺基苯甲酸协同二氯二茂钛水相高效制备喹啉衍生物的方法 | |
CN107382998A (zh) | 一种含氟香豆素噻唑类化合物及其合成方法 | |
CN1149188C (zh) | 芳氨基亚甲基樟脑衍生物 | |
KR20230121826A (ko) | 2-(4'-디에틸아미노-2'-히드록시벤조일)벤조산 헥실에스테르의 제조 방법 | |
CN107474021B (zh) | 噁二嗪衍生物及其制备方法和应用 | |
CN1127250A (zh) | 2,3-桥连的1,4-二氢吡啶类化合物及其制法和其药用 | |
Chanti Babu et al. | Total Synthesis of (−)‐Cleistenolide | |
CN1059442C (zh) | 1,2-桥连的1,4-二氢吡啶类化合物作为药物的用途 | |
WO2009097951A1 (de) | Uva filter auf der basis von ascorbinsäurederivaten | |
CN1425653A (zh) | 2,4,5-三取代咪唑类化合物及其制备方法和制药用途 | |
CN1106376C (zh) | 肉桂叉樟脑衍生物和它们作为uv-a-光防护剂的应用 | |
EP3583103B1 (en) | Plant extracts enriched with ipolamiide derivatives as immunosuppressants for treating immunological disorders | |
KR101042103B1 (ko) | 도미노 알돌형 반응 및 6π―전자고리화 반응을 이용한 피라노스틸벤 화합물의 합성방법 | |
DE19624154A1 (de) | Ringannelierte Dihydropyrane, Verfahren zur Herstellung sowie deren Verwendung | |
EP3604291A1 (en) | Compound or salt thereof, antiviral agent, and pharmaceutical composition | |
EP2285793A1 (de) | Uvb filter auf der basis von ascorbinsäurederivaten | |
CN1417218A (zh) | 山奈酚衍生物及其医药用途 | |
US6734313B2 (en) | Synthesis of spiro esters, spiro ortho carbonates, and intermediates | |
EP0300249A1 (de) | 7-[1H-Pyrrol-3-yl]-substituierte 3,5-Dihydroxy-heptansäuren, ihre entsprechenden delta-Lactone und Salze, Verfahren zu ihrer Herstellung, ihre Verwendung als Arzneimittel, pharmazeutische Präparate und Zwischenprodukte | |
US6613918B1 (en) | Synthesis of spiro ortho esters, spiro ortho carbonates, and intermediates | |
DE102019129221B4 (de) | Verfahren zur Synthese von DOPA mit einer fotolabilen Schutzgruppe und Zwischenprodukten zu dessen Herstellung | |
DE60215217T2 (de) | Substituierte arylcycloalkane und deren verwendung als antikrebsmittel | |
EP2709731B1 (de) | Extrakte aus darlingtonia californica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |